Gravier Pierre
CHIEF FINANCIAL OFFICER
Gravier Pierre has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 16, 2026.
On the most recent filing, Gravier Pierre is listed as CHIEF FINANCIAL OFFICER at PTC THERAPEUTICS, INC. Inside the rolling window, Gravier Pierre reported no open-market purchases and 3 open-market sales totaling $653K in PTCT. The largest disclosed transaction in the window is a sale of 3,494 PTCT shares on Jul 14, 2026, worth $281K.
Companies traded
Other insiders at PTCT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$653K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gravier Pierre made?
Gravier Pierre has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Gravier Pierre trade?
Gravier Pierre has filed SEC Form 4 disclosures for 1 company, including PTCT.
When was Gravier Pierre's most recent SEC Form 4 filing?
Gravier Pierre's most recent SEC Form 4 filing on Tracefour is dated Jul 16, 2026.
What is Gravier Pierre's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gravier Pierre is listed as CHIEF FINANCIAL OFFICER.
What is Gravier Pierre's total buy and sell value in the current window?
Inside the rolling retention window, Gravier Pierre bought $0 and sold $653K based on SEC Form 4 filings.
What was Gravier Pierre's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,494 PTCT shares on 2026-07-14, worth $281K, per SEC Form 4 filings.